tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GILD Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
24h ago
RSP
UMC
Gilead price target raised to $120 from $105 at Bernstein
PremiumThe Fly
Gilead price target raised to $120 from $105 at Bernstein
1d ago
GILD
Gilead Sciences: Buy Rating Backed by Strong Q4 Performance, Strategic Initiatives, and Promising Pipeline
PremiumRatings
Gilead Sciences: Buy Rating Backed by Strong Q4 Performance, Strategic Initiatives, and Promising Pipeline
1d ago
GILD
Gilead’s Seladelpar granted conditional European marketing authorization
PremiumThe Fly
Gilead’s Seladelpar granted conditional European marketing authorization
2d ago
GILD
Gilead call volume above normal and directionally bullish
PremiumThe Fly
Gilead call volume above normal and directionally bullish
2d ago
GILD
Assembly Biosciences reports positive Phase 1a results in genital herpes
PremiumThe FlyAssembly Biosciences reports positive Phase 1a results in genital herpes
2d ago
ASMB
GILD
Arcus Biosciences price target lowered to $17 from $22 at BofA
Premium
The Fly
Arcus Biosciences price target lowered to $17 from $22 at BofA
3d ago
GILD
RCUS
Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright
Premium
The Fly
Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright
4d ago
GILD
RCUS
Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls
4d ago
FN
GE
Gilead announces FDA acceptance of lenacapavir NDA submissions
PremiumThe Fly
Gilead announces FDA acceptance of lenacapavir NDA submissions
4d ago
GILD
Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
PremiumThe Fly
Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
4d ago
MRK
GILD
Deutsche upgrades Gilead to Buy on ability to offset patent cliffs
PremiumThe Fly
Deutsche upgrades Gilead to Buy on ability to offset patent cliffs
4d ago
GILD
Arcus Biosciences retains rights to casdatifan
PremiumThe FlyArcus Biosciences retains rights to casdatifan
4d ago
GILD
RCUS
Gilead upgraded to Buy from Hold at Deutsche Bank
Premium
The Fly
Gilead upgraded to Buy from Hold at Deutsche Bank
4d ago
GILD
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
Premium
Ratings
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
5d ago
GILD
Senate votes to confirm Robert Kennedy as head of HHS
PremiumThe Fly
Senate votes to confirm Robert Kennedy as head of HHS
9d ago
JNJ
MRK
Gilead price target raised to $116 from $109 at BofA
PremiumThe Fly
Gilead price target raised to $116 from $109 at BofA
9d ago
GILD
Ideaya Biosciences enters additional supply pact with Gilead for IDE397
PremiumThe Fly
Ideaya Biosciences enters additional supply pact with Gilead for IDE397
9d ago
GILD
IDYA
Gilead Sciences: Strong Financial Performance and Promising Future Prospects Drive Optimistic Outlook
PremiumRatings
Gilead Sciences: Strong Financial Performance and Promising Future Prospects Drive Optimistic Outlook
9d ago
GILD
Gilead upgraded to Buy from Hold at DZ Bank
PremiumThe FlyGilead upgraded to Buy from Hold at DZ Bank
9d ago
GILD
Gilead Sciences: Strong Performance and Growth Potential in HIV and Oncology Segments Boost Buy Rating
Premium
Ratings
Gilead Sciences: Strong Performance and Growth Potential in HIV and Oncology Segments Boost Buy Rating
9d ago
GILD
Gilead Sciences’ Earnings Call: Strong Growth Amid Challenges
Premium
Company Announcements
Gilead Sciences’ Earnings Call: Strong Growth Amid Challenges
10d ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >